Table 4.
Multivariate analysis of factors prognostic for overall survival and progression‐free survival in patients with diffuse large B cell lymphoma
Variable | Overall survival | Progression‐free survival | Bootstrap probability | ||||
---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | ||
Multivariate analysis including IPI score | |||||||
B Sx | 1.780 | 1.234–2.567 | 0.002 | 1.857 | 1.321–2.609 | 0.0001 | 0.964 |
VEGFR2 rs1870377 | 1.729 | 1.227–2.438 | 0.002 | 1.635 | 1.189–2.247 | 0.002 | 0.926 |
IPI | |||||||
Low risk | 1 | 0.0001 | 1 | 0.0001 | 0.215 | ||
Low–intermediate | 1.870 | 1.131–3.091 | 1.500 | 0.949–2.373 | |||
High–intermediate | 2.562 | 1.561–4.205 | 2.363 | 1.526–3.660 | |||
High | 4.410 | 2.671–7.280 | 3.103 | 1.944–4.951 | |||
Multivariate analysis including IPI variables | |||||||
Age >60 years | 2.148 | 1.524–3.028 | 0.0001 | 1.925 | 1.403–2.640 | 0.0001 | 0.971 |
LDH >normal | 1.843 | 1.235–2.748 | 0.003 | 1.851 | 1.286–2.666 | 0.001 | 0.974 |
Extranodal >1 | 1.564 | 1.081–2.264 | 0.018 | 1.457 | 1.030–2.060 | 0.033 | 0.859 |
B Sx | 2.020 | 1.407–2.900 | 0.0001 | 2.035 | 1.459–2.838 | 0.0001 | 0.964 |
VEGFR2 rs1870377 | 1.645 | 1.165–2.324 | 0.005 | 1.565 | 1.137–2.153 | 0.006 | 0.926 |
95% CI, 95% confidence interval; HR, hazard ratio; IPI, International Prognostic Index; LDH, lactate dehydrogenase.